Management of the Sensitized Cardiac Transplantation Recipient
Abstract
(ISSN 2577-5820)
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Special Issue
Perspectives on Heart Transplantation
Submission Deadline: January 31, 2019 (Open) Submit Now
Guest Editor
Kumud K. Dhital, BSc BM.BCh FRCS (Eng) FRCS-CTh.(UK) PhD FRACS
Associate Professor, Heart & Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia; Department of Cardiothoracic Surgery, St Vincent's Hospital, Sydney, NSW, Australia; The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Randwick, NSW, Australia
Research Interests: Adult cardiac surgery; Heart Lung Transplantation; Thoracic Trauma and Reconstructive Surgery and surgery for Heart/Lung failure; Pulmonary Endarterectomy; Cardiothoracic Surgery
Publication
Management of the Sensitized Cardiac Transplantation RecipientAbstract Preoperative sensitization of the cardiac transplant recipient, defined as the presence of anti-Human Leukocyte Antigen (HLA) antibodies before transplant, represents a significant management challenge for physicians. Sensitization prolongs the pre-transplant wait time and is associated with postoperative transplant complications and death [...] |
Characterization of Early Indicators of Cardiac Allograft Vasculopathy Lesions in a Rat Model Using Non-Invasive Cellular MRby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Background: Cardiac allograft vasculopathy (CAV) remains a major obstacle to long-term heart allograft survival. A number of studies show that immune mechanisms involved in CAV. Using non-invasive cellular MRI (CMRI) to explore indicators of CAV lesions and characterize its development could provide new insights into the target immune cells [...] |
Mortality Risk Factors in Patients who are in Heart Transplantation Waiting Listby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Purpose: to estimate the survival of patients in a heart transplantation waiting list (HTxWL) at V.A.Almazov NMRC from 2010 to 2017 and to define risk factors for death among these patients. Materials and methods: A single-centre retrospective study of 151 patients with advanced chronic heart failure (CHF) in HTxWL. Results and conclusion: [...] |
Ex-Vivo Perfusion of Donor Hearts: The Feasibility of Banked Blood for Normothermic Machine Perfusionby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Background:
Normothermic machine perfusion (NMP) utilises 1.2-1.5L of donor blood (DB) with a target perfusate haematocrit of 25% to reanimate the donor heart. Limitations to current practise include small donor size and donor anaemia which can impact on the recovery of these hearts. Furthermore, in DCD, blood collection delays delivery of [...] |
Update in the Use of Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy After Heart Transplantationby
![]() ![]() Abstract Cardiac allograft vasculopathy (CAV) limits long-term survival after heart transplantation. CAV with discrete or tubular lesions can be treated with percutaneous coronary intervention (PCI) with high procedural success. Revascularization with balloon angioplasty, bare-metal stents, and first-generation drug-eluting stents has been associated [...] |
Right Heart Failure in Left Ventricular Assist Device Patientsby
![]() ![]() Abstract Left ventricular assist devices (LVADs) improve quality of life in end-stage heart failure patients but a frequent complication is Right heart failure (RHF) causing significant morbidity and mortality. This review article discusses key issues that need to be considered in the assessment and clinical management of RHF in LVAD patients including [...] |
The Contribution of Psychotherapists to Patient Care in Multidisciplinary Heart Transplantation Care Teamsby
![]() ![]() ![]() ![]() ![]() Abstract Background: The participation of mental health professionals in multidisciplinary care teams for heart transplantation has advanced to international standard practice. The contribution of mental health interventions to patient outcomes in this setting have not been the subject of systematic study.
Methods: This paper uses a case study for [...] |
Candida auris and Heart Transplantation. Preoperative Attitude.by
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract In recent years, several agencies have issued warnings about the spread of Candida auris infections, a multi-resistant yeast that is associated with serious infections and with mortality rates as high as 70% with a mortality rate that can reach 70%. This problem is especially serious in patients who are candidates for transplantation, who [...] |
Sex and Gender Issues in Heart Transplantation |
TOP